Grande Pharmacie Moderne - Apothical - 🤒 🤧 Prêts à affronter l'hiver? 🤧 🤒 🦠 PEDIAKID® Nez-Gorge 🦠 ✔️actifs naturels pour apaiser et dégager les voies respiratoires (nez, gorge, bronches…), dès les
Emilie Bonnet - Responsable unité de production chez BIOCODEX - Beauvais, Hauts-de-France, France | LinkedIn
Emilie Bonnet - Responsable unité de production chez BIOCODEX - Beauvais, Hauts-de-France, France | LinkedIn
Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment | ACS Synthetic Biology
Emilie Bonnet - Responsable unité de production chez BIOCODEX - Beauvais, Hauts-de-France, France | LinkedIn
![Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment | ACS Synthetic Biology Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment | ACS Synthetic Biology](https://pubs.acs.org/cms/10.1021/acssynbio.2c00314/asset/images/large/sb2c00314_0004.jpeg)
Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment | ACS Synthetic Biology
![Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study - Digestive and Liver Disease Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study - Digestive and Liver Disease](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2d1e2471-a241-4226-9e0d-72e8170c0872/gr1_lrg.jpg)
Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study - Digestive and Liver Disease
![PDF) AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms PDF) AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms](https://i1.rgstatic.net/publication/358208129_AhRIL-22_pathway_as_new_target_for_the_treatment_of_post-infectious_irritable_bowel_syndrome_symptoms/links/61fc215caad5781d41cbdc68/largepreview.png)